Neuropeptide variability in man.

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Neuroendocrinology

Background:

• Previous research confirmed short-term variability in circulating cardiac peptides like ANP and BNP.
• This study aimed to determine if similar variability exists for other vasoactive peptides.

Purpose of the Study:

• To investigate short-term variability in plasma levels of vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), endothelin-1 (ET-1), and calcitonin gene-related peptide (CGRP).
• To compare these patterns between patients with chronic cardiac failure (CCF) and healthy controls.
• To examine peptide levels across different vascular beds in individuals with normal cardiac function.

Main Methods:

• Peripheral venous blood samples were collected at 2-minute intervals over 20 minutes from CCF patients and controls.
• In a separate cohort, blood was sampled from the pulmonary artery, femoral artery, and antecubital vein at 2-minute intervals in individuals with normal cardiac function.
• Immunoreactivity of VIP, NPY, ET-1, and CGRP was measured in all samples.

Main Results:

• VIP, NPY, and ET-1 exhibited significant peaks and troughs approximately every 10 minutes in both patient and control groups.
• Calcitonin gene-related peptide (CGRP) levels showed minimal variation.
• Circulating VIP and NPY levels were higher in CCF patients compared to controls, while ET-1 and CGRP levels were similar between groups.

Conclusions:

• Circulating levels of VIP, NPY, and ET-1 demonstrate marked, pulsatile variability, occurring every 10-15 minutes across different vascular beds.
• Single measurements of these vasoactive peptides may require cautious interpretation due to their dynamic secretion patterns.
• The findings prompt further investigation into the physiological mechanisms of hormone secretion in humans.